Sam-A Pharm. Co., Ltd (KOSDAQ:009300)
South Korea · Delayed Price · Currency is KRW 12,200
-10 (-0.08%)
At close: Aug 3, 2026
Sam-A Pharm. Financials Overview
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Revenue Revenue Growth | 70,928 | 77,799 | 95,581 | 97,211 | 81,700 | 54,666 |
Revenue Growth | -21.30% | -18.60% | -1.68% | 18.99% | 49.45% | 1.89% |
Gross Profit Gross Profit Growth | 40,216 | 46,051 | 60,651 | 61,279 | 50,163 | 32,658 |
Operating Income Operating Income Growth | 5,624 | 10,979 | 24,466 | 23,500 | 18,253 | 6,048 |
Net Income Net Income Growth | 8,887 | 12,940 | 22,080 | 21,374 | 11,912 | 3,392 |
Earnings Per Share EPS Growth | 1456.16 | 2120.12 | 3618.00 | 3502.00 | 1951.65 | 555.68 |
EPS Growth | -53.22% | -41.40% | 3.31% | 79.44% | 251.22% | 2678.42% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Investments Cash & Investments Growth | 102,186 | 97,642 | 76,664 | 79,104 | 81,011 | 53,623 |
Total Debt Total Debt Growth | 5,409 | 6,942 | 12,890 | 11,669 | 1,770 | 5,625 |
Net Cash (Debt) Net Cash Growth | 96,777 | 90,700 | 63,774 | 67,435 | 79,241 | 47,998 |
Net Cash Growth | 32.48% | 42.22% | -5.43% | -14.90% | 65.09% | -16.01% |
Net Cash Per Share Net Cash Per Share Growth | 15858.06 | 14860.70 | 10450.12 | 11048.85 | 12983.19 | 7864.24 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Operating Cash Flow Operating Cash Flow Growth | 9,722 | 10,723 | 25,247 | 20,760 | 19,604 | 12,943 |
Capital Expenditures CapEx Growth | -1,694 | -1,370 | -6,512 | -3,820 | -239.25 | -275.44 |
Free Cash Flow Free Cash Flow Growth | 8,029 | 9,353 | 18,735 | 16,940 | 19,365 | 12,667 |
Free Cash Flow Growth | -49.89% | -50.08% | 10.60% | -12.52% | 52.88% | 45.13% |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Gross Margin | 56.70% | 59.19% | 63.46% | 63.04% | 61.40% | 59.74% |
Operating Margin | 7.93% | 14.11% | 25.60% | 24.17% | 22.34% | 11.06% |
Pretax Margin | 14.81% | 20.61% | 30.62% | 29.29% | 22.52% | 9.76% |
Profit Margin | 12.53% | 16.63% | 23.10% | 21.99% | 14.58% | 6.20% |
FCF Margin | 11.32% | 12.02% | 19.60% | 17.43% | 23.70% | 23.17% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Dividend Per Share Dividend Per Share Growth | 850.000 | - | - | 750.000 | 400.000 | 250.000 |
Dividend Per Share Growth | 6.25% | - | - | 87.50% | 60.00% | -16.67% |
Dividend Yield | 6.96% | - | - | 5.06% | 2.78% | 1.53% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Aug '26 Aug 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
PE Ratio | 8.39 | 7.41 | 4.62 | 4.68 | 8.53 | 34.82 |
P/FCF Ratio | 9.28 | 10.25 | 5.44 | 5.91 | 5.25 | 9.32 |
PS Ratio | 1.05 | 1.23 | 1.07 | 1.03 | 1.24 | 2.16 |